Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Cash from Financing Activities (2016 - 2025)

Bruker's Cash from Financing Activities history spans 16 years, with the latest figure at -$167.6 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 123.47% year-over-year to -$167.6 million; the TTM value through Dec 2025 reached $135.1 million, down 89.01%, while the annual FY2025 figure was $135.1 million, 89.01% down from the prior year.
  • Cash from Financing Activities reached -$167.6 million in Q4 2025 per BRKRP's latest filing, down from $258.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $1.2 billion in Q2 2024 to a low of -$217.4 million in Q1 2022.
  • Average Cash from Financing Activities over 5 years is $53.7 million, with a median of -$37.1 million recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: plummeted 3053.85% in 2022, then surged 11321.36% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $404.3 million in 2021, then tumbled by 108.93% to -$36.1 million in 2022, then plummeted by 65.93% to -$59.9 million in 2023, then dropped by 25.21% to -$75.0 million in 2024, then plummeted by 123.47% to -$167.6 million in 2025.
  • Per Business Quant, the three most recent readings for BRKRP's Cash from Financing Activities are -$167.6 million (Q4 2025), $258.4 million (Q3 2025), and $95.5 million (Q2 2025).